Literature DB >> 19933168

Novel sequence feature variant type analysis of the HLA genetic association in systemic sclerosis.

David R Karp1, Nishanth Marthandan, Steven G E Marsh, Chul Ahn, Frank C Arnett, David S Deluca, Alexander D Diehl, Raymond Dunivin, Karen Eilbeck, Michael Feolo, Paula A Guidry, Wolfgang Helmberg, Suzanna Lewis, Maureen D Mayes, Chris Mungall, Darren A Natale, Bjoern Peters, Effie Petersdorf, John D Reveille, Barry Smith, Glenys Thomson, Matthew J Waller, Richard H Scheuermann.   

Abstract

We describe a novel approach to genetic association analyses with proteins sub-divided into biologically relevant smaller sequence features (SFs), and their variant types (VTs). SFVT analyses are particularly informative for study of highly polymorphic proteins such as the human leukocyte antigen (HLA), given the nature of its genetic variation: the high level of polymorphism, the pattern of amino acid variability, and that most HLA variation occurs at functionally important sites, as well as its known role in organ transplant rejection, autoimmune disease development and response to infection. Further, combinations of variable amino acid sites shared by several HLA alleles (shared epitopes) are most likely better descriptors of the actual causative genetic variants. In a cohort of systemic sclerosis patients/controls, SFVT analysis shows that a combination of SFs implicating specific amino acid residues in peptide binding pockets 4 and 7 of HLA-DRB1 explains much of the molecular determinant of risk.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19933168      PMCID: PMC2807365          DOI: 10.1093/hmg/ddp521

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  37 in total

1.  Autoantigenic epitopes on DNA topoisomerase I. Clinical and immunogenetic associations in systemic sclerosis.

Authors:  M Kuwana; J Kaburaki; T Mimori; T Tojo; M Homma
Journal:  Arthritis Rheum       Date:  1993-10

2.  HLA and ethnic associations among systemic sclerosis patients with anticentromere antibodies.

Authors:  P A Morel; H J Chang; J W Wilson; C Conte; D Falkner; D J Tweardy; T A Medsger
Journal:  Hum Immunol       Date:  1995-01       Impact factor: 2.850

3.  A molecular and serologic analysis of the major histocompatibility complex and complement component C4 in systemic sclerosis.

Authors:  D Briggs; C Stephens; R Vaughan; K Welsh; C Black
Journal:  Arthritis Rheum       Date:  1993-07

4.  Severe systemic sclerosis with anti-topoisomerase I antibodies is associated with an HLA-DRw11 allele.

Authors:  P A Morel; H J Chang; J W Wilson; C Conte; S L Saidman; J D Bray; D J Tweardy; T A Medsger
Journal:  Hum Immunol       Date:  1994-06       Impact factor: 2.850

5.  Association of polar amino acids at position 26 of the HLA-DQB1 first domain with the anticentromere autoantibody response in systemic sclerosis (scleroderma).

Authors:  J D Reveille; D Owerbach; R Goldstein; R Moreda; R A Isern; F C Arnett
Journal:  J Clin Invest       Date:  1992-04       Impact factor: 14.808

6.  DNA-DR typing shows HLA-DRw11 RFLPs are increased in frequency in both progressive systemic sclerosis and CREST variants of scleroderma.

Authors:  H Dunckley; E C Jazwinska; P A Gatenby; S W Serjeantson
Journal:  Tissue Antigens       Date:  1989-03

7.  The HLA-DR and DQ genes control the autoimmune response to DNA topoisomerase I in systemic sclerosis (scleroderma).

Authors:  M Kuwana; J Kaburaki; Y Okano; H Inoko; K Tsuji
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

8.  Association of amino acid sequences in the HLA-DQB1 first domain with antitopoisomerase I autoantibody response in scleroderma (progressive systemic sclerosis).

Authors:  J D Reveille; E Durban; M J MacLeod-St Clair; R Goldstein; R Moreda; R D Altman; F C Arnett
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

9.  HLA-DQB1 associations with anti-topoisomerase-1 antibodies in patients with systemic sclerosis and their first degree relatives. United Kingdom Systemic Sclerosis Study Group.

Authors:  J Whyte; C Artlett; G Harvey; C O Stephens; K Welsh; C Black; P J Maddison; N J McHugh
Journal:  J Autoimmun       Date:  1994-08       Impact factor: 7.094

10.  Connective tissue disease in southeast Georgia. A community based study of immunogenetic markers and autoantibodies.

Authors:  F C Arnett; W B Bias; R H McLean; M Engel; M Duvic; R Goldstein; L Freni-Titulaer; T W McKinley; M C Hochberg
Journal:  J Rheumatol       Date:  1990-08       Impact factor: 4.666

View more
  23 in total

Review 1.  Cutaneous squamous cell cancer (cSCC) risk and the human leukocyte antigen (HLA) system.

Authors:  Pooja Yesantharao; Wei Wang; Nilah M Ioannidis; Shadmehr Demehri; Alice S Whittemore; Maryam M Asgari
Journal:  Hum Immunol       Date:  2017-02-07       Impact factor: 2.850

2.  Conditional asymmetric linkage disequilibrium (ALD): extending the biallelic r2 measure.

Authors:  Glenys Thomson; Richard M Single
Journal:  Genetics       Date:  2014-07-14       Impact factor: 4.562

3.  Sarcoidosis HLA class II genotyping distinguishes differences of clinical phenotype across ethnic groups.

Authors:  Hiroe Sato; Felix A Woodhead; Tariq Ahmad; Jan C Grutters; Paolo Spagnolo; Jules M M van den Bosch; Lisa A Maier; Lee S Newman; Sonoko Nagai; Takateru Izumi; Athol U Wells; Roland M du Bois; Kenneth I Welsh
Journal:  Hum Mol Genet       Date:  2010-08-03       Impact factor: 6.150

4.  Influenza virus sequence feature variant type analysis: evidence of a role for NS1 in influenza virus host range restriction.

Authors:  Jyothi M Noronha; Mengya Liu; R Burke Squires; Brett E Pickett; Benjamin G Hale; Gillian M Air; Summer E Galloway; Toru Takimoto; Mirco Schmolke; Victoria Hunt; Edward Klem; Adolfo García-Sastre; Monnie McGee; Richard H Scheuermann
Journal:  J Virol       Date:  2012-03-07       Impact factor: 5.103

Review 5.  Interrogating the major histocompatibility complex with high-throughput genomics.

Authors:  Paul I W de Bakker; Soumya Raychaudhuri
Journal:  Hum Mol Genet       Date:  2012-09-12       Impact factor: 6.150

Review 6.  IL-17: overview and role in oral immunity and microbiome.

Authors:  L Abusleme; N M Moutsopoulos
Journal:  Oral Dis       Date:  2016-12-27       Impact factor: 3.511

Review 7.  The genetics of scleroderma.

Authors:  Javier Martin; Carmen Fonseca
Journal:  Curr Rheumatol Rep       Date:  2011-02       Impact factor: 4.592

8.  Recursive organizer (ROR): an analytic framework for sequence-based association analysis.

Authors:  Lue Ping Zhao; Xin Huang
Journal:  Hum Genet       Date:  2013-03-14       Impact factor: 4.132

9.  Sequence feature variant type (SFVT) analysis of the HLA genetic association in juvenile idiopathic arthritis.

Authors:  Glenys Thomson; Nishanth Marthandan; Jill A Hollenbach; Steven J Mack; Henry A Erlich; Richard M Single; Matthew J Waller; Steven G E Marsh; Paula A Guidry; David R Karp; Richard H Scheuermann; Susan D Thompson; David N Glass; Wolfgang Helmberg
Journal:  Pac Symp Biocomput       Date:  2010

10.  Patient HLA Germline Variation and Transplant Survivorship.

Authors:  Effie W Petersdorf; Philip Stevenson; Mari Malkki; Roland K Strong; Stephen R Spellman; Michael D Haagenson; Mary M Horowitz; Ted Gooley; Tao Wang
Journal:  J Clin Oncol       Date:  2018-06-14       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.